• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines Piperazine carboxylic acids and derivatives

tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate (CAS No. 1353947-81-5): A Comprehensive Overview

tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate (CAS No. 1353947-81-5) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique chemical structure, has garnered attention for its potential in the development of novel therapeutic agents. In this article, we will delve into the chemical properties, synthesis methods, and recent research advancements related to this compound.

Chemical Structure and Properties

tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate is a derivative of piperazine, a six-membered heterocyclic amine. The compound features a tert-butyl group attached to the carboxylate moiety, which provides steric protection and enhances its stability. The presence of a 2-chloroacetyl group introduces reactivity and functional versatility, making it an attractive intermediate in organic synthesis. The molecular formula of tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate is C₁₃H₂₀ClNO₃, with a molecular weight of approximately 277.75 g/mol.

The compound exhibits good solubility in polar organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), which facilitates its use in various chemical reactions and biological assays. Its melting point is reported to be around 85-87°C, and it is stable under standard laboratory conditions.

Synthesis Methods

The synthesis of tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate can be achieved through several well-documented methods. One common approach involves the reaction of tert-butyl piperazine-1-carboxylate with 2-chloroacetyl chloride in the presence of a base such as triethylamine or pyridine. This reaction typically proceeds via nucleophilic acylation, leading to the formation of the desired product with high yield and purity.

            tert-Butyl piperazine-1-carboxylate + 2-Chloroacetyl chloride → tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate
        

An alternative synthetic route involves the reaction of tert-butyl 4-acetyl-2-methylpiperazine-1-carboxylate with chlorine gas or N-chlorosuccinimide (NCS) to introduce the chloro substituent. This method offers a more controlled approach to chlorination and can be optimized for large-scale production.

Applications in Medicinal Chemistry

tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate has found extensive applications in medicinal chemistry due to its structural diversity and reactivity. One notable area of research is its use as an intermediate in the synthesis of CNS-active compounds. The chloroacetyl group can be readily functionalized to introduce various pharmacophores, enabling the development of drugs targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression.

Recent studies have also explored the potential of tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate as a scaffold for antiviral agents. For instance, researchers at the University of California have synthesized derivatives of this compound that exhibit potent antiviral activity against influenza A virus. These derivatives are believed to interfere with viral replication by targeting specific viral enzymes.

Clinical Trials and Therapeutic Potential

The therapeutic potential of compounds derived from tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate is currently being evaluated in several clinical trials. One such trial focuses on a novel antipsychotic drug that incorporates this scaffold. Preliminary results have shown promising efficacy in treating symptoms of schizophrenia without significant side effects, suggesting a potential breakthrough in psychiatric pharmacology.

In another study, researchers at Harvard Medical School have developed a series of compounds based on this scaffold that demonstrate anti-inflammatory properties. These compounds are being tested for their ability to reduce inflammation in chronic diseases such as rheumatoid arthritis and Crohn's disease. Early findings indicate that these compounds may offer a safer alternative to existing anti-inflammatory drugs by minimizing gastrointestinal side effects.

Safety and Handling

tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate should be handled with care due to its reactivity and potential for forming hazardous byproducts when exposed to certain conditions. It is recommended to store the compound in a cool, dry place away from strong acids and bases. Personal protective equipment (PPE) such as gloves, goggles, and lab coats should be worn during handling to minimize exposure risks.

In case of accidental exposure, immediate medical attention should be sought. The Material Safety Data Sheet (MSDS) for this compound provides detailed information on safe handling procedures and emergency response measures.

Conclusion

tert-Butyl 4-(2-chloroacetyl)-2-methylpiperazine-1-carboxylate (CAS No. 1353947-81-5) is a valuable compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and reactivity make it an attractive intermediate for the synthesis of novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new possibilities for this compound, highlighting its significance in advancing drug discovery and development efforts.

• 1354010-55-1((R)-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester)
• 1312455-25-6(tert-Butyl 2-((2-chloroacetamido)methyl)pyrrolidine-1-carboxylate)
• 865432-10-6(tert-Butyl 3-(2-chloroacetamido)pyrrolidine-1-carboxylate)
• 1312455-22-3(tert-Butyl 2-((2-chloroacetamido)methyl)piperidine-1-carboxylate)
• 1353975-27-5(tert-Butyl 4-(2-chloroacetyl)-3-methylpiperazine-1-carboxylate)
• 929047-18-7(1-Pyrrolidinecarboxylic acid, 2-[[(2-chloroacetyl)amino]methyl]-,1,1-dimethylethyl ester, (2S)-)
• 929047-20-1(1-Pyrrolidinecarboxylic acid, 2-[[(2-chloroacetyl)amino]methyl]-,1,1-dimethylethyl ester, (2R)-)
• 190001-40-2(tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate)
• 1353998-17-0((R)-tert-Butyl 3-(2-chloroacetamido)pyrrolidine-1-carboxylate)
• 335280-33-6((S)-tert-Butyl 3-(2-chloroacetamido)pyrrolidine-1-carboxylate)